查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198465

脊柱植入物和手术器械市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Spinal Implants and Surgical Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内（2022 年至 2027 年），脊柱植入物和手术器械市场预计将以 5.6% 的复合年增长率增长。

COVID-19 大流行不仅对感染 COVID-19 的患者产生了重大影响，对其他患者也产生了重大影响，导致脊柱手术被取消以管理和节约资源，导致许多医院面临短缺协助这些手术的专家，影响了该国的医疗保健系统。 例如，在 2020 年 5 月发表的题为“由于 COVID-19 大流行导致的选择性手术取消：为手术恢復计划提供信息的全球预测模型”的英国外科杂誌上，印度报告称大约有 48,728 次手术被取消，并且它预计 12 週内将进行约 585,000 台手术。 因此，考虑到上述因素，它可能在 COVID-19 流行期间对研究中的市场产生重大影响。 全球 COVID-19 病例数量的增加预计将影响市场的增长。

脊柱植入物和手术器械市场的主要驱动力是脊柱疾病负担的增加、微创手术需求的增加以及骨移植产品的技术进步。 脊髓疾病 (SD) 和相关疼痛是一个主要的医学、社会和经济问题，因为它们在普通人群中的患病率很高，而且患者人数不断增加。 根据英国脊髓损伤协会 2021，每年约有 2500 人受伤或被诊断出脊髓损伤，估计英国有 50,000 人患有脊髓损伤。 对于 SD，患者会经历假关节疼痛，其中大部分是由于脊柱的退行性变化，涉及椎间盘、小关节和软组织。

脊柱相关疾病是临床医学中最常遇到的问题之一。 收购也是市场增长的驱动力之一。 例如，2020 年 11 月，美敦力收购了 Medicrea International，该公司专门从事具有人工智能、预测建模和患者特异性植入物的脊柱外科手术。 同样，2021 年 2 月，NuVasive, Inc. 收购了 Simplify Medical，这是一家私人控股的 Simplify Cervical Artificial Disc（Simplify Disc）开发商，用于全颈椎置换术（cTDR）。 因此，这样的市场发展将促进未来的市场增长。

颈椎病、椎间盘脱落、椎管狭窄、椎间盘突出和椎体骨折等脊柱疾病发病率的增加正在推动全球脊柱植入物和手术器械市场的发展。 因此，脊柱治疗和设备中新颖有效技术的开发有望推动对这些植入物和设备的需求。 然而，高昂的治疗成本和严格的监管审批程序可能会阻碍市场增长。

脊柱植入物和手术器械的市场趋势

预计在预测期内微创手术将保持显着的市场增长

研究的增加、技术创新以及主要参与者之间的合作伙伴关係等因素预计会增加市场份额。 灌注技术的创新、脊柱融合的改进以及专业手术器械和机器人技术的发展提供了将脊柱手术推进到微创方法所需的工具。 微创脊柱手术 (MIS) 的目标是稳定椎骨和脊柱关节并减轻脊神经的压力，通常是由于脊柱不稳定、骨赘、椎间盘突出、脊柱侧凸和脊柱肿瘤等疾病造成的。它是关于减轻。

微创脊柱手术的许多发展有望促进市场的增长。 例如，2020 年 7 月，joimax 与澳大利亚医疗器械经销商 LifeHealthcare 建立了新的合作伙伴关係，通过微创内窥镜脊柱手术为考虑进行脊柱手术的患者提供广泛的手术选择。 同样，2021 年 10 月，专注于治疗脊柱疾病的手术解决方案的全球医疗技术公司 SeaSpine Holdings Corporation 在美国和澳大利亚完成了 7D 经皮脊柱模块的首例稻田。 7D Flash Navigation System 使 SeaSpine 能够应对全球估计约 40 亿美元的微创脊柱手术市场。 7D 经皮模块的加入使微创脊柱手术程序能够以高精度和高效率进行有效导航。 这种技术进步正在影响研究目标市场的全球增长。

因此，由于上述因素，预计在预测期内市场将出现显着的市场增长。

在预测期内，北美将占据所研究市场的很大份额

北美脊柱植入物和手术器械市场占有很大份额，预计在预测期内将呈现类似趋势。 该地区的增长受到技术进步、期望更高水平功能的老年患者以及鼓励复杂融合手术的报销模式的推动，这有助于推动脊柱植入物和手术器械市场。

产品批准也是市场增长的一个因素。 例如，2020 年 12 月，ActaStim-S 脊柱融合刺激器获得 FDA（食品和药物管理局）的批准。 这是一种小型、可穿戴、非手术骨生长刺激器 (BGS)，包括可充电电池组和充电装置，以及带导线的电极。 BGS 向佩戴在臀□□部的电极输送电流，以促进骨骼生长并支持脊柱融合。

同样，2020 年 3 月，Orthofix Medical Inc. 完成了与用于股骨和胫骨肢体延长的 FITBONE 髓内延长系统相关的资产收购。 此次收购还包括其他正在开发的潜在技术，包括 FITSPINE，这是一种用于治疗早发性脊柱侧凸的非癒合手术系统。

同样，2020 年 12 月，Zimmer Biomet 收购了新泽西州的 A&E Medical Corporation 及其整个胸骨闭合装置产品组合。 该地区主要市场参与者的此类发展预计将促进未来的市场增长。

因此，由于上述因素，预计在预测期内北美地区的市场将显着增长。

脊柱植入物和手术器械市场竞争分析

这个市场竞争相当激烈，有几家大大小小的参与者。 市场参与者关注技术进步和产品成本降低。 市场上的主要参与者包括 Alphatec Spine Inc.、Depuy Synthes（强生）、Globus Medical Inc.、NuVasive Inc、Orthofix Holdings Inc、RTI Surgical Inc、Stryker Corporation、Zimmer Biomet。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 脊柱疾病负担加重
    • 对微创手术的需求不断增长
    • 植骨材料技术进展
  • 市场製约因素
    • 手术费用高
    • 严格的监管审批程序
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按技术
    • 脊柱固定和融合技术
    • 椎体压缩性骨折治疗技术
    • 运动维护/非工会技术
    • 其他技术
  • 按产品分类
    • 用于胸椎和腰椎融合的设备
    • 颈椎固定装置
    • 椎体压缩性骨折治疗仪
    • 脊柱生物製剂
    • 非融合装置
    • 脊柱骨骼刺激器
    • 其他产品
  • 按手术类型
    • 开放手术
    • 微创手术
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Alphatec Spine Inc.
    • Depuy Synthes（Johnson & Johnson）
    • Globus Medical Inc.
    • Spineart
    • Medtronic Plc
    • NuVasive Inc.
    • Orthofix Holdings Inc.
    • RTI Surgical Inc
    • Stryker Corporation
    • Zimmer Biomet
    • Advin Healthcare
    • DeGen Medical Inc.
    • Osseus

第7章 市场机会与今后动向

简介目录
Product Code: 64428

The spinal implants and surgical devices market is projected to register a CAGR of 5.6% during the forecast period (2022-2027).

The COVID-19 pandemic had an effect on the country's healthcare systems with significant impacts not only on the patients infected with COVID-19 but on others as well, which resulted in the cancellation of spinal surgeries to manage and reserve the resources and many hospitals are facing a shortage of professionals to assist these surgeries. For instance, the British Journal of Surgery article titled 'Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans' published in May 2020 reported that around 48,728 surgical procedures per week were canceled in India which estimates around 585,000 surgical procedures for 12 weeks. Thus, given the above-mentioned factors, there could be a significant impact on the studied market during the COVID-19 pandemic. The increasing cases of COVID-19 globally, it is likely to show an impact on the market growth.

The spinal implants and surgical devices market is primarily driven by the increasing burden of spinal disorders, rising demand for minimally-invasive surgeries, and technological advancements in bone grafting products. Spine disorders (SD) and the associated pain are a major medical, social, and economic problem, due to their high prevalence and the ever-increasing number of patients in the general population. According to Spinal Injury Association United Kingdom 2021, about 2500 people are injured or diagnosed with spinal cord injuries every year and an estimated 50,000 people are living with spinal cord injuries in the United Kingdom. In most SD cases, patients experience pseudo-radicular pain, and in the majority, the pain results from degenerative changes in the spine, involving the intervertebral discs, facet joints, and soft tissues.

Spine-related disorders are among the most frequently encountered problems in clinical medicine. The acquisition is another factor in the growth of the market. For instance, in November 2020, Medtronic acquired Medicrea International which specializes in spinal surgery through artificial intelligence, predictive modeling, and patient-specific implants. Similarly, in February 2021, NuVasive, Inc. acquired Simplify Medical, a privately held company and developer of the Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). Hence, such developments would increase market growth in the future.

The increasing incidence of spinal disorders, such as cervical spondylitis, prolapsed intervertebral disc, spinal stenosis, herniated disc, and vertebral fracture, helped in driving the spinal implants and surgical devices market, globally. Hence, the development of novel and effective technologies in spine care and devices is anticipated to drive the demand for these implants and devices. However, the high cost of the procedures and stringent regulatory approval procedures are likely to hinder the market growth.

Spinal Implants & Surgical Devices Market Trends

Minimally Invasive Surgery is Expected to Hold the Significant Market Growth Over the Forecast Period

Factors such as increasing research studies, and technological innovations coupled with partnerships between key market players are likely to increase the market share. With innovations in perfusion techniques, refinement of spinal fusion, and the development of specialized surgical instruments and robotic technology, spinal surgery was provided with the necessary tools to progress to less invasive approaches. The goal of the minimally invasive spine (MIS) surgery is to stabilize the vertebral bones and spinal joints and/or relieve the pressure being applied to the spinal nerves often a result of conditions such as spinal instability, bone spurs, herniated discs, scoliosis or spinal tumors.

Many developments are taking place concerning minimally invasive spine surgery which will boost the market growth. For instance, in July 2020, joimax entered into a new partnership with Australian medical device distributor, LifeHealthcare to provide a broader surgical choice for patients considering spinal surgery with minimally invasive endoscopic spine surgery. Similarly, in October 2021, SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, completed the first cases in both the United States and Australia for the 7D Percutaneous Spine Module. 7D Flash Navigation System allows SeaSpine to address the minimally invasive spine surgery market, which SeaSpine estimates at approximately USD 4 billion worldwide. The addition of the 7D Percutaneous Module allows effectively navigating minimally invasive spine surgery procedures with a high level of accuracy and efficiency. Such technological advancements are impacting the growth of the studied market globally.

Thus, owing to the abovementioned factors the market is expected to have significant market growth over the forecast period.

North America accounted for the Large Share in the Studied Market Over the Forecast Period

North American spinal implants and surgical devices market holds a significant share and is expected to show a similar trend over the forecast period. The growth in the region is driven by technological advancement, elderly patients expecting a higher level of function, and reimbursement models that incentivize complex fusion surgery and have helped in driving the spinal implants and surgical devices market.

Product approval is another factor in the growth of the market. For instance, in December 2020, ActaStim-S Spine Fusion Stimulator was approved by the Food and Drug Administration (FDA). It is a small, wearable, nonsurgical bone growth stimulator (BGS) device, that includes a rechargeable battery pack and charging unit, and electrodes with lead wires. The BGS sends an electrical current to the electrodes attached to the lower back to promote bone growth and support spinal fusion.

Similarly, in March 2020, Orthofix Medical Inc. completed the acquisition of assets associated with the FITBONE intramedullary lengthening system for limb lengthening of the femur and tibia bones. The transaction also includes other potential applications of the technology which are in development, including the FITSPINE system for fusion-less surgery to treat early-onset scoliosis.

Similarly, in December 2020, Zimmer Biomet acquired New Jersey-based A&E Medical Corporation and its complete portfolio of sternal closure devices. Such developments by the key market players in the region are likely to increase the market growth in the upcoming period.

Thus, owing to the abovementioned factors the market is expected to have significant growth in the North American region over the forecast period.

Spinal Implants & Surgical Devices Market Competitor Analysis

The market studied is moderately competitive, owing to the presence of a few major and small players in the market. The market players are focusing on technological advancements and reducing the cost of the products. Some of the major players in the market are Alphatec Spine Inc., Depuy Synthes (Johnson & Johnson), Globus Medical Inc., NuVasive Inc., Orthofix Holdings Inc., RTI Surgical Inc., Stryker Corporation, and Zimmer Biomet.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Spinal Disorders
    • 4.2.2 Rising Demand for Minimally-invasive Surgeries
    • 4.2.3 Technological Advancements in Bone Grafting Products
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Procedures
    • 4.3.2 Stringent Regulatory Approval Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Spinal Fusion and Fixation Technologies
    • 5.1.2 Vertebral Compression Fracture Treatment
    • 5.1.3 Motion Preservation/Non-fusion Technologies
    • 5.1.4 Other Technologies
  • 5.2 By Product
    • 5.2.1 Thoracic Fusion and Lumbar Fusion Devices
    • 5.2.2 Cervical Fusion Devices
    • 5.2.3 Vertebral Compression Fracture Treatment Devices
    • 5.2.4 Spinal Biologics
    • 5.2.5 Non-fusion Devices
    • 5.2.6 Spine Bone Stimulators
    • 5.2.7 Other Products
  • 5.3 By Type of Surgery
    • 5.3.1 Open Surgery
    • 5.3.2 Minimally-invasive Surgery
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alphatec Spine Inc.
    • 6.1.2 Depuy Synthes (Johnson & Johnson)
    • 6.1.3 Globus Medical Inc.
    • 6.1.4 Spineart
    • 6.1.5 Medtronic Plc
    • 6.1.6 NuVasive Inc.
    • 6.1.7 Orthofix Holdings Inc.
    • 6.1.8 RTI Surgical Inc
    • 6.1.9 Stryker Corporation
    • 6.1.10 Zimmer Biomet
    • 6.1.11 Advin Healthcare
    • 6.1.12 DeGen Medical Inc.
    • 6.1.13 Osseus

7 MARKET OPPORTUNITIES AND FUTURE TRENDS